[Benign prostate hyperplasia. Need to evaluate quality of life in the therapeutic process].

Autor:	Bobé Armant F; EAP Tárraco. Institut Català de la Salut. Tarragona. España. elsmua@comt.es, Buil Arasanz ME, Allué Buil AI, Morro Grau A, Maxenchs Esteban M, Gens Barberà M
Jazyk:	Spanish; Castilian
Zdroj:	Atencion primaria [Aten Primaria] 2006 Oct 31; Vol. 38 (7), pp. 387-91.
DOI:	10.1016/s0212-6567(06)70530-3
Abstrakt:	Objective: To relate the symptoms of benign prostate hyperplasia (BPH) to their repercussions on quality of life. Design: Multi-centred, observational, prospective study. Setting: Primary care. Participants: Men with BPH in 2000-2003. Inclusion criteria were: agreeing to take part, being aged 50-79, and having moderate symptoms evaluated by means of the IPSS questionnaire. Exclusion Criteria: Previous treatment for BPH and having a chronic or disabling illness that might affect perception of quality of life. The presence of irritative and obstructive symptoms was appraised. Main Measurements: The IPSS questionnaire appraising predominant symptoms and, through the last question, quality of life was self-administered. Descriptive statistics were worked out and differences in proportions of the different groups were analysed by the chi2 test, with differences taken as significant at P < .05. Results: We got 536 replies, with average age 66.2. Nycturia was the most common symptom, suffered by 88.1% of patients. A total of 256 patients (47.8%) had irritation as main clinical symptom, and 280 (52.2%), obstruction. On analysing repercussions on quality of life, it was found that obstructive symptoms were worse tolerated: 65.7% versus 9.4% of the group with irritation. Conclusions: In treating BPH, we must bear in mind preferences of patients. They tolerate obstructive symptoms worse, and these are a criterion for referral to specialists and even surgery.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu